Healthy Clinical Trial
Official title:
Evaluating the Alimentary and Respiratory Tracts in Health and Disease (EARTH) Research Program.
The investigators have established the "Evaluating the Alimentary and Respiratory Tracts in
Health and disease" (EARTH) research program. It provides a structured approach to analysing
gastrointestinal and respiratory microbiomes, along with diet and symptomatology, in children
with a gastrointestinal and/or respiratory condition with recognised long-term morbidity
(e.g. cystic fibrosis, obstructive sleep apnoea, or Hirschsprung's disease).
The EARTH program consists of a series of prospective, longitudinal, controlled,
observational studies, with each individual study comparing children with a chronic
gastrointestinal and/or respiratory condition to healthy controls (HC). It will be conducted
in an Australian tertiary paediatric hospital (although the methodology is applicable to
other settings). Children with a chronic gastrointestinal and/or respiratory condition will
be compared to age and gender matched HC across a 12-month period. The following will be
collected at baseline, 6 and 12 months: (i) a stool sample, (ii) an oropharyngeal swab or
sputum sample, (iii) a semi-quantitative food frequency questionnaire, (iv) details of
disease symptomatology, (v) health-related quality of life, and (vi) psychosocial factors.
Data on the intestinal and respiratory microbiomes and diet will be compared between children
with a condition and HC. Correlations between dietary intake (energy, macro- and
micro-nutrients), intestinal and respiratory microbiomes within each group will be explored.
Data on disease symptomatology, quality of life and psychosocial factors will also be
compared between children with a condition and HC.
The investigators hypothesise that:
(i) Children with chronic gastrointestinal and/or respiratory conditions will have altered
intestinal and respiratory microbiomes compared to healthy children, and (ii) Diet plays a
key role in influencing the intestinal and respiratory microbiomes and this may impact on
clinical outcomes, biomarkers of disease, and health-related quality of life.
The objective of this research program is to evaluate and compare children with a chronic
gastrointestinal and/or respiratory condition and age and gender matched HC. The primary
objectives include analysing the intestinal and respiratory microbiomes (using an integrated
"omics" approach) and dietary intake using validated, food frequency quetsionnaires. The
secondary objectives include evaluating:
1. Known inflammatory biomarkers.
2. Symptomatology and health-related quality of life (HRQOL) using validated measures.
3. Phenotypic and clinical information.
4. Sociodemographic factors Additional secondary objectives include correlating within
children with the same condition: (i) dietary intake with the intestinal microbiome;
(ii) dietary intake with the respiratory microbiome; and (iii) the intestinal and
respiratory microbiomes.
The investigators hypothesise that:
(i) Children with chronic gastrointestinal and/or respiratory conditions will have altered
intestinal and respiratory microbiomes compared to healthy children, and (ii) Diet plays a
key role in influencing the intestinal and respiratory microbiomes and this may impact on
clinical outcomes, biomarkers of disease, and health-related quality of life.
To our knowledge, this program will enable the first series of studies comparing the
intestinal and respiratory microbiomes and diet in children with chronic gastrointestinal
and/or respiratory conditions. Initial results will be hypothesis-generating and used to
direct future studies tailored to a specific focus or line of inquiry. Additionally, studies
from this research program have potential for direct translation into clinical care as diet
is a highly modifiable factor.
Study design. The EARTH program provides a framework for a series of prospective,
longitudinal, controlled, observational studies, with each individual study comparing
children with a chronic gastrointestinal and/or respiratory condition to HC. A single healthy
control group will be used for comparison against all conditions. The standardised
methodological approach will also allow for comparisons between different health conditions.
Procedures.
Each participant will be assessed on three occasions over a 12-month period; at study entry,
6- and 12-month follow-up. At each time-point, the following will be collected:
- A stool sample;
- An oropharyngeal swab or sputum sample (a sputum sample will be obtained in children
able to expectorate and an oropharyngeal swab will be collected in children unable to
expectorate);
- Dietary intake measured using the Australian Child and Adolescent Eating Survey (ACAES)
(2 to 18 years) or 24-hour food recall (0 up to 2 years);
- A secure, password-protected online survey comprising:
i. PedsQL Infant Scales (0-2yr) & Gastrointestinal Symptoms Module (2-18yr),41-43
tailored to age; ii. Rome IV Questionnaire (0 to 18 years); iii. Spence Children's
Anxiety Scale (3 to 18 years); iv. Short Mood and Feelings Questionnaires (6 to 18
years); v. Clinical and biochemical results obtained through routine care and
hospitalisations (if available); vi. Sociodemographic factors (baseline survey only);
- Anthropometrics: height, weight and BMI z-scores.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |